Azurrx biopharma, inc. (AZRX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Dec'15
ASSETS
Current Assets:
Cash

1,630

175

1,549

1,310

413

1,114

4,427

7,420

574

573

2,946

3,828

531

1,773

128

581

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

56

Other receivables

760

2,637

2,090

2,119

2,051

3,172

1,197

1,081

1,015

1,104

173

978

1,010

961

250

1,074

Prepaid expenses

507

595

89

198

338

512

58

132

216

274

64

223

207

229

982

353

Total Current Assets

2,897

3,408

3,729

3,628

2,803

4,800

5,683

8,634

1,805

1,952

3,184

5,030

1,750

2,963

1,361

2,067

Property, equipment, and leasehold improvements, net

73

77

95

108

125

128

136

145

148

133

147

150

141

151

163

176

Other Assets:
In process research & development, net

-

-

0

0

0

258

271

282

306

307

309

309

298

301

330

345

License agreements, net

-

-

-

-

-

311

488

665

883

1,038

1,190

1,326

1,401

1,534

1,806

2,238

License agreements, net

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Patents, net

3,275

3,407

3,538

3,670

3,802

0

-

-

-

-

-

-

-

-

-

-

Goodwill

1,844

1,886

1,832

1,913

1,887

1,924

1,952

1,966

2,071

2,016

1,973

1,917

1,797

1,767

1,888

1,832

Operating lease right-of-use assets

53

82

189

241

288

0

-

-

-

-

-

-

-

-

-

-

Deposits

40

41

48

49

49

45

45

45

31

30

30

30

34

34

35

25

Total Other Assets

5,213

5,417

5,610

5,875

6,027

2,540

2,758

2,960

3,293

3,393

3,503

3,583

3,532

3,638

4,060

4,442

Total Assets

8,184

8,902

9,435

9,612

8,956

7,469

8,578

11,739

5,247

5,479

6,836

8,764

5,423

6,753

5,585

6,685

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable and accrued expenses

1,039

1,754

2,754

3,041

2,580

2,070

826

1,259

1,797

1,187

1,533

1,023

1,696

1,471

1,760

781

Accounts payable and accrued expenses - related party

396

533

525

627

643

670

639

1,035

699

868

854

857

870

707

636

636

Notes payable

279

444

0

64

160

255

0

26

80

159

-

26

77

155

-

0

Convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

135

Convertible debt

-

-

-

-

-

0

-

-

-

257

-

-

-

0

9,931

6,442

Convertible debt

2,986

1,076

1,947

1,837

1,728

-

0

281

235

-

379

645

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3,214

818

Interest payable

-

-

-

-

-

-

0

7

7

7

7

7

7

7

7

1

Other current liabilities

441

476

592

650

643

0

-

-

-

-

-

-

-

-

-

-

Total Current Liabilities

5,143

4,285

5,819

6,221

5,756

2,995

1,466

2,610

2,819

2,479

2,730

2,559

2,652

2,340

15,551

8,815

Other liabilities

-

-

414

443

486

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration

-

-

-

-

-

0

1,580

1,500

1,330

1,340

1,310

1,560

1,300

1,200

2,400

1,500

Total Liabilities

5,143

4,285

6,233

6,664

6,243

2,995

3,046

4,110

4,149

3,819

4,040

4,119

3,952

3,540

17,951

10,315

Stockholders' Equity:
Convertible preferred stock 0 Par value $0.0001 per share; 10,000,000 shares authorized and 0 shares issued and outstanding at March 31, 2019 and December 31, 2018; liquidation preference approximates par value

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

3,479

Common stock 0 Par value $0.0001 per share; 100,000,000 shares authorized; 27,1157,651 and 26,800,519 shares issued and outstanding, respectively, at March 31, 2020 and December 31, 2019

2

2

2

2

1

1

1

1

1

1

1

1

0

0

0

0

Additional paid in capital

72,103

68,575

65,969

61,385

56,134

53,139

50,123

49,611

39,563

37,669

35,319

34,181

28,566

27,560

6,102

2,532

Subscriptions receivable

-

-

-

-

-

-

0

0

0

1,071

-

-

-

0

-

-

Accumulated deficit

-67,956

-62,694

-61,413

-57,220

-52,177

-47,517

-43,497

-40,925

-37,616

-33,983

-31,502

-28,368

-25,696

-22,887

-17,255

-8,295

Accumulated other comprehensive loss

-1,109

-1,266

-1,357

-1,218

-1,245

-1,150

-1,095

-1,059

-849

-955

-1,022

-1,170

-1,400

-1,461

-1,213

-1,346

Total Stockholders' Equity

3,041

4,617

3,201

2,948

2,713

4,473

5,532

7,628

1,098

1,660

2,795

4,644

1,471

3,213

-12,365

-3,629

Total Liabilities and Stockholders' Equity

8,184

8,902

9,435

9,612

8,956

7,469

8,578

11,739

5,247

5,479

6,836

8,764

5,423

6,753

5,585

6,685